The Use of Hexacapron in Upper Gastrointestinal Bleeding

• Status: Unknown status
• Trial end date: 2015-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to conduct a randomized control trial, double-blind study to compare Hexacapron with standard of care treatment to standard of care alone to evaluate the efficacy of adding effect of Hexacapron to standard therapy by decreasing the episodes of rebleeding and mortality in patient with upper gastrointestinal bleeding.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shaare Zedek Medical Center
• Treatments: Esomeprazole; Tranexamic Acid

Criteria

Inclusion Criteria:

• Patients 18≤ years of age admitted to emergency department in Shaare Zedek MedicalCenter with clinical signs, symptoms and laboratory of upper gastrointestinal bleeding

• Hospitalized patients in Shaare Zedek Medical Center with clinical signs, symptoms and laboratory of upper gastrointestinal bleeding

• Patients , guardian or family member who can sign on informed consent

Exclusion Criteria:

Pregnancy, lactation

• History of thromboembolic event

• Allergic reaction to the drug

• Lower gastrointestinal bleeding

• Patient receive anticoagulation treatment

• Receive drug with interaction to hexacapron